Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8+ responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera

Priya Chikhlikar, Luciana Barros De Arruda, Shikha Agrawal, Barry Byrne, William B Guggino, Thomas August, Ernesto T A Marques

Research output: Contribution to journalArticle

Abstract

The immune responses to an HIV-1 p55Gag vaccine encoded as a DNA chimera with the lysosomal associated membrane protein-1 (LAMP) have been examined for the effect of the addition of the inverted terminal repeat (ITR) sequences of the adeno-associated virus (AAV) to the DNA plasmid construct, and of packaging the LAMP/gag gene as a recombinant AAV vector (rAAV). DNA plasmids encoding Gag and the LAMP/Gag protein chimera were constructed in two vectors, the pcDNA3.1 and a corresponding plasmid containing the ITR sequences (pITR) flanking the expression elements of the plasmid, and the pITR LAMP/gag DNA plasmid was encapsidated in the rAAV vector. Human 293 cells transfected in vitro with LAMP/gag plasmids either in pcDNA3.1 or pITR produced much Gag protein in cell extracts (1.6 and 2.2 ng of Gag/mg of protein, respectively). The immune responses of mice to immunization with these constructs were examined under three protocols: DNA prime/DNA boost, DNA prime/rAAV boost, and a single rAAV immunization. The results demonstrated that under DNA prime/DNA boost protocol, the "naked" DNA vaccines encoding the LAMP/gag chimera, either as pcDNA3.1 or pITR DNA plasmid constructs, elicited strong CD4+ T cell responses. In contrast, significantly higher levels of CD8+ and antibody responses were observed with the pITR-DNA constructs. Immunization with the rAAV vector under the DNA prime/rAAV boost protocol resulted in sustained T cell responses and a markedly increased antibody response, predominantly of the IgG1 isotype resulting from the activation of the Th2 subset of CD4+ T cells, that was sustained for at least 5 months after immunization.

Original languageEnglish (US)
Pages (from-to)220-232
Number of pages13
JournalVirology
Volume323
Issue number2
DOIs
StatePublished - Jun 1 2004

Fingerprint

Lysosomal-Associated Membrane Protein 1
Inverted Repeat Sequences
Dependovirus
DNA Vaccines
Terminal Repeat Sequences
Antibody Formation
HIV-1
Plasmids
DNA
gag Gene Products
Immunization
Recombinant DNA
gag Genes
T-Lymphocytes
T-Lymphocyte Subsets
Product Packaging
Cell Extracts

Keywords

  • AAV
  • antigen presenting cell
  • APC
  • CD4
  • CD8
  • DNA vaccine
  • HIV-1 Gag
  • Inverted terminal repeat
  • LAMP
  • lysosome-associated membrane protein
  • major histocompatibility complex
  • MHC
  • MHC class II-enriched compartment
  • MHC II
  • MIIC
  • rAAV
  • Rev-responsive elements
  • RRE

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8+ responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera. / Chikhlikar, Priya; Barros De Arruda, Luciana; Agrawal, Shikha; Byrne, Barry; Guggino, William B; August, Thomas; Marques, Ernesto T A.

In: Virology, Vol. 323, No. 2, 01.06.2004, p. 220-232.

Research output: Contribution to journalArticle

Chikhlikar, Priya ; Barros De Arruda, Luciana ; Agrawal, Shikha ; Byrne, Barry ; Guggino, William B ; August, Thomas ; Marques, Ernesto T A. / Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8+ responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera. In: Virology. 2004 ; Vol. 323, No. 2. pp. 220-232.
@article{af5141e85d4c40858083b977ca0f9cda,
title = "Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8+ responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera",
abstract = "The immune responses to an HIV-1 p55Gag vaccine encoded as a DNA chimera with the lysosomal associated membrane protein-1 (LAMP) have been examined for the effect of the addition of the inverted terminal repeat (ITR) sequences of the adeno-associated virus (AAV) to the DNA plasmid construct, and of packaging the LAMP/gag gene as a recombinant AAV vector (rAAV). DNA plasmids encoding Gag and the LAMP/Gag protein chimera were constructed in two vectors, the pcDNA3.1 and a corresponding plasmid containing the ITR sequences (pITR) flanking the expression elements of the plasmid, and the pITR LAMP/gag DNA plasmid was encapsidated in the rAAV vector. Human 293 cells transfected in vitro with LAMP/gag plasmids either in pcDNA3.1 or pITR produced much Gag protein in cell extracts (1.6 and 2.2 ng of Gag/mg of protein, respectively). The immune responses of mice to immunization with these constructs were examined under three protocols: DNA prime/DNA boost, DNA prime/rAAV boost, and a single rAAV immunization. The results demonstrated that under DNA prime/DNA boost protocol, the {"}naked{"} DNA vaccines encoding the LAMP/gag chimera, either as pcDNA3.1 or pITR DNA plasmid constructs, elicited strong CD4+ T cell responses. In contrast, significantly higher levels of CD8+ and antibody responses were observed with the pITR-DNA constructs. Immunization with the rAAV vector under the DNA prime/rAAV boost protocol resulted in sustained T cell responses and a markedly increased antibody response, predominantly of the IgG1 isotype resulting from the activation of the Th2 subset of CD4+ T cells, that was sustained for at least 5 months after immunization.",
keywords = "AAV, antigen presenting cell, APC, CD4, CD8, DNA vaccine, HIV-1 Gag, Inverted terminal repeat, LAMP, lysosome-associated membrane protein, major histocompatibility complex, MHC, MHC class II-enriched compartment, MHC II, MIIC, rAAV, Rev-responsive elements, RRE",
author = "Priya Chikhlikar and {Barros De Arruda}, Luciana and Shikha Agrawal and Barry Byrne and Guggino, {William B} and Thomas August and Marques, {Ernesto T A}",
year = "2004",
month = "6",
day = "1",
doi = "10.1016/j.virol.2004.02.025",
language = "English (US)",
volume = "323",
pages = "220--232",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8+ responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera

AU - Chikhlikar, Priya

AU - Barros De Arruda, Luciana

AU - Agrawal, Shikha

AU - Byrne, Barry

AU - Guggino, William B

AU - August, Thomas

AU - Marques, Ernesto T A

PY - 2004/6/1

Y1 - 2004/6/1

N2 - The immune responses to an HIV-1 p55Gag vaccine encoded as a DNA chimera with the lysosomal associated membrane protein-1 (LAMP) have been examined for the effect of the addition of the inverted terminal repeat (ITR) sequences of the adeno-associated virus (AAV) to the DNA plasmid construct, and of packaging the LAMP/gag gene as a recombinant AAV vector (rAAV). DNA plasmids encoding Gag and the LAMP/Gag protein chimera were constructed in two vectors, the pcDNA3.1 and a corresponding plasmid containing the ITR sequences (pITR) flanking the expression elements of the plasmid, and the pITR LAMP/gag DNA plasmid was encapsidated in the rAAV vector. Human 293 cells transfected in vitro with LAMP/gag plasmids either in pcDNA3.1 or pITR produced much Gag protein in cell extracts (1.6 and 2.2 ng of Gag/mg of protein, respectively). The immune responses of mice to immunization with these constructs were examined under three protocols: DNA prime/DNA boost, DNA prime/rAAV boost, and a single rAAV immunization. The results demonstrated that under DNA prime/DNA boost protocol, the "naked" DNA vaccines encoding the LAMP/gag chimera, either as pcDNA3.1 or pITR DNA plasmid constructs, elicited strong CD4+ T cell responses. In contrast, significantly higher levels of CD8+ and antibody responses were observed with the pITR-DNA constructs. Immunization with the rAAV vector under the DNA prime/rAAV boost protocol resulted in sustained T cell responses and a markedly increased antibody response, predominantly of the IgG1 isotype resulting from the activation of the Th2 subset of CD4+ T cells, that was sustained for at least 5 months after immunization.

AB - The immune responses to an HIV-1 p55Gag vaccine encoded as a DNA chimera with the lysosomal associated membrane protein-1 (LAMP) have been examined for the effect of the addition of the inverted terminal repeat (ITR) sequences of the adeno-associated virus (AAV) to the DNA plasmid construct, and of packaging the LAMP/gag gene as a recombinant AAV vector (rAAV). DNA plasmids encoding Gag and the LAMP/Gag protein chimera were constructed in two vectors, the pcDNA3.1 and a corresponding plasmid containing the ITR sequences (pITR) flanking the expression elements of the plasmid, and the pITR LAMP/gag DNA plasmid was encapsidated in the rAAV vector. Human 293 cells transfected in vitro with LAMP/gag plasmids either in pcDNA3.1 or pITR produced much Gag protein in cell extracts (1.6 and 2.2 ng of Gag/mg of protein, respectively). The immune responses of mice to immunization with these constructs were examined under three protocols: DNA prime/DNA boost, DNA prime/rAAV boost, and a single rAAV immunization. The results demonstrated that under DNA prime/DNA boost protocol, the "naked" DNA vaccines encoding the LAMP/gag chimera, either as pcDNA3.1 or pITR DNA plasmid constructs, elicited strong CD4+ T cell responses. In contrast, significantly higher levels of CD8+ and antibody responses were observed with the pITR-DNA constructs. Immunization with the rAAV vector under the DNA prime/rAAV boost protocol resulted in sustained T cell responses and a markedly increased antibody response, predominantly of the IgG1 isotype resulting from the activation of the Th2 subset of CD4+ T cells, that was sustained for at least 5 months after immunization.

KW - AAV

KW - antigen presenting cell

KW - APC

KW - CD4

KW - CD8

KW - DNA vaccine

KW - HIV-1 Gag

KW - Inverted terminal repeat

KW - LAMP

KW - lysosome-associated membrane protein

KW - major histocompatibility complex

KW - MHC

KW - MHC class II-enriched compartment

KW - MHC II

KW - MIIC

KW - rAAV

KW - Rev-responsive elements

KW - RRE

UR - http://www.scopus.com/inward/record.url?scp=2942532790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942532790&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2004.02.025

DO - 10.1016/j.virol.2004.02.025

M3 - Article

C2 - 15193918

AN - SCOPUS:2942532790

VL - 323

SP - 220

EP - 232

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -